Electra_Logo

A Pipeline Shaped by Innovation

All of our programs are first-in-class and internally generated, each representing an opportunity to make a transformational impact across numerous diseases with high unmet need.

POC=proof-of-concept.
IND=investigational new drug.
sHLH=secondary hemophagocytic lymphohistiocytosis.
TCL=T cell lymphoma.
T-ALL=T cell acute lymphoblastic leukemia.

Explore how ELA026 works and offers hope for people living with sHLH

POC=proof-of-concept.
IND=investigational new drug.
sHLH=secondary hemophagocytic lymphohistiocytosis.
TCL=T cell lymphoma.
T-ALL=T cell acute lymphoblastic leukemia.

Explore how ELA026 works and offers hope for people living with sHLH